Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 22 of 22 entries
View as:

Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Participants With Primary Biliary Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT01865812 Org: User:
Start: 12/03/13 End: 09/12/16 Due: 09/12/17

Study of INT-747 as Monotherapy in Participants With Primary Biliary Cirrhosis (PBC)

Phase: N/A Priority: Normal
NCT ID: NCT00570765 Org: User:
Start: 01/17/08 End: 09/25/17 Due: 09/25/18

Obeticholic Acid in Pediatric Subjects With Biliary Atresia

Phase: N/A Priority: Normal
NCT ID: NCT05321524 Org: User:
Start: 07/01/15 End: 03/09/23 Due: 03/09/24

Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Obeticholic Acid (OCA) Compared to Placebo in Pediatric Participants With Biliary Atresia, Post-hepatoportoenterostomy

Phase: N/A Priority: Normal
NCT ID: NCT06121375 Org: User:
Start: 09/02/24 End: 12/31/27 Due: 12/31/28

Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL)

Phase: N/A Priority: Normal
NCT ID: NCT02633956 Org: User:
Start: 12/04/15 End: 03/12/18 Due: 03/12/19

Study of Obeticholic Acid (OCA) Evaluating Pharmacokinetics and Safety in Participants With Primary Biliary Cholangitis (PBC) and Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT03633227 Org: User:
Start: 06/22/18 End: 07/09/21 Due: 07/09/22

Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis

Phase: N/A Priority: Normal
NCT ID: NCT02308111 Org: User:
Start: 12/26/14 End: 12/23/21 Due: 12/23/22

FXR Effect on Severe Alcohol-Associated Hepatitis (FRESH) Study

Phase: N/A Priority: Normal
NCT ID: NCT05639543 Org: User:
Start: 12/15/22 End: 04/01/27 Due: 04/01/28

Effect of Food on Pharmacokinetics of Obeticholic Acid (OCA)

Phase: N/A Priority: Normal
NCT ID: NCT01914562 Org: User:
Start: 08/31/13 End: 11/30/13 Due: 11/30/14

A Real-World Data Study to Evaluate the Effectiveness of OCA on Hepatic Outcomes in PBC Patients

Phase: N/A Priority: Normal
NCT ID: NCT05293938 Org: User:
Start: 03/28/22 End: 07/31/23 Due: 07/31/24

To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate

Phase: N/A Priority: Normal
NCT ID: NCT06488911 Org: User:
Start: 07/01/24 End: 03/31/30 Due: 03/31/31

Study of OCA in Combination with BZF Evaluating Efficacy, Safety, and Tolerability in Participants with PBC

Phase: N/A Priority: Normal
NCT ID: NCT04594694 Org: User:
Start: 10/02/19 End: 10/31/25 Due: 10/31/26

Single Dose and Multiple Dose Trial to Assess Pharmacokinetics of Obeticholic Acid (OCA)

Phase: N/A Priority: Normal
NCT ID: NCT01933503 Org: User:
Start: 10/31/13 End: 11/30/13 Due: 11/30/14

Phase 3 Study of Obeticholic Acid in Patients With Primary Biliary Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT01473524 Org: User:
Start: 01/31/12 End: 12/17/18 Due: 12/17/19

Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis

Phase: N/A Priority: Normal
NCT ID: NCT03439254 Org: User:
Start: 08/30/17 End: 09/08/22 Due: 09/08/23

Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBC

Phase: N/A Priority: Normal
NCT ID: NCT05239468 Org: User:
Start: 03/21/22 End: 10/01/25 Due: 10/01/26

Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC)

Phase: N/A Priority: Normal
NCT ID: NCT02177136 Org: User:
Start: 02/09/15 End: 03/22/18 Due: 03/22/19

Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment

Phase: N/A Priority: Normal
NCT ID: NCT02548351 Org: User:
Start: 09/22/15 End: 09/15/23 Due: 09/15/24

Study of INT-747 in Patients With Diabetes and Presumed NAFLD

Phase: N/A Priority: Normal
NCT ID: NCT00501592 Org: User:
Start: 07/31/07 End: 04/30/09 Due: 04/30/10

Study of INT 747 in Combination With URSO in Patients With Primay Biliary Cirrhosis (PBC)

Phase: N/A Priority: Normal
NCT ID: NCT00550862 Org: User:
Start: 10/31/07 End: 12/31/10 Due: 12/31/11

Real-World Data Study to Evaluate the Effectiveness of OCA on Hepatic Outcomes in PBC Patients

Phase: N/A Priority: Normal
NCT ID: NCT05292872 Org: User:
Start: 06/01/15 End: 12/31/21 Due: 12/31/22

Hepatic Impairment Trial of Obeticholic Acid

Phase: N/A Priority: Normal
NCT ID: NCT01904539 Org: User:
Start: 06/30/13 End: 10/31/13 Due: 10/31/14